Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 652-656

  Park, Eun Kyung ^a   Shin, Yong Wook ^a   Lee, Hae Ung ^a   Kim, Sung Soo ^b   Lee, Young Churl ^b   Lee, Boo Yong ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Compound K; COX 2; Ginseng; Inducible NO synthase (iNOS); Inflammation

Indexed keywords

20 O BETA DEXTRO GLUCOPYRANOSYL 20 PROTOPANAXADIOL; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG METABOLITE; GINSENOSIDE RB 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROTOPANAXADIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARALIACEAE; ARTICLE; CELL FREE SYSTEM; CELL STRAIN; CELL STRAIN RAW264.7; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG EXCRETION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GINSENG; IC 50; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; PLANT ROOT; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT; URINARY EXCRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION; GINSENOSIDES; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 21144444049     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.652     Document Type: Article

References (23)

1. Shibata S., Fujita M., Itokawa H., Tanaka O., Ishii T., Chem. Pharm. Bull., 11, 759-764 (1963).
2. Tanaka N., Tanaka O., Shibata S., Chem. Pharm. Bull., 20, 1212-1216 (1972).
3. Wu J. Y., Gardner B. H., Murphy C. I., Seals J. R., Kenstl C. R., Recchia J., Beltz G. A., Newman G. W., Newman M. J., J. Immunol., 148, 1519-1525 (1992).
4. Mochizuki M., Yoo C. Y., Matsuzawa K., Sato K., Saiki I., Tono-oka S., Samukawa K., Azuma I., Biol. Pharm. Bull., 18, 1197-1202 (1995).
5. Wakabayashi C., Hasegawa H., Murata J., Saiki I., Oncol. Res., 9, 411-417 (1998).
6. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K., J. Pharm. Pharmacol., 50, 1155-1160 (1998).
7. Bae E. A., Han M. J., Choo M. K., Park S. Y., Kim D.-H., Biol. Pharm. Bull., 25, 58-63 (2002).
8. Hasegawa H., Sung J. H., Benno Y., Planta Med., 63, 436-440 (1997).
9. Odani T., Tantzawa H., Tantko Y., Chem. Pharm. Bull., 31, 3691-3697 (1983).
10. Park E. K., Choo M. K., Han M. J., Kim D.-H., Int. Arch. Allergy Immunol., 133, 113-120 (2004).
11. Oh G. S., Pae H. O., Choi B. M., Seo E. A., Kim D. H., Shin M. K., Kim J. D., Kim J. B., Chung H. T., Cancer Lett., 205, 23-29 (2004).
12. Hasegawa H., Sung J. H., Matsumiya S., Uchtyama M., Planta Med., 62, 453-457 (1996)
13. Choo M. K., Park E. K., Han M. J., Kim D.-H., Planta Med, 69, 518-522 (2003).
14. Ryu S. Y., Ock M. H., Kim K. M., Planta Med., 66, 171-173 (2000).
15. Ishihara T., Kohno K., Ushio S., Iwaki K., Ikeda M., Kurimoto M., Eur. J. Pharmacol., 407, 197-204 (2000).
16. Stevens R. L., Austen K. F., Immunol. Today, 10, 381-386 (1989).
17. Ohmori H., Hideki M., Takaki T., Eur. J. Immunol., 20, 2499-2503 (1990).
18. Abd-El-Aleem S. A., Feguson M. W., Appleton I., Bhowmick A., McCollum C. N., Ireland G. W., J. Patho., 195, 616-623 (2001).
19. Bruch-Gerharz D., Fehsel K., Suschek C., Michel G., Ruzicka T., Kolba-Bachofen V., J. Exp. Med., 184, 2007-2012 (1996).
20. Bruch-Gerharz D., Ruzicka T., Kolb-Bachofen V., J. Invest. Dermatol., 110, 1-7 (1998).
21. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K., J. Pharm. Pharmacol., 50, 1155-1160 (1988).
22. Akao T., Kanaoka M., Kobashi K., Biol. Pharm. Bull., 21, 245-249 (1988).
23. Bae E. A., Park S. Y., Kim D.-H., Biol. Pharm. Bull., 23, 1481-1485 (2000).